Trial Outcomes & Findings for Mobile Health for Alcohol Use Disorders in Clinical Practice (NCT NCT04011644)
NCT ID: NCT04011644
Last Updated: 2025-01-23
Results Overview
Percentage of self-reported Heavy Drinking Days (HDD: 5 or more standard drinks on any day for men under 65, 4 or more standard drinks for women and men over 65) in the last 7 days
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
558 participants
Primary outcome timeframe
12 months
Results posted on
2025-01-23
Participant Flow
A three-pronged recruitment strategy encompassing clinical settings, community-based organizations, and public media was used. Clinical study champions, including primary care providers, behavioral health specialists, etc., provided information to potentially eligible patients. Leaders from underrepresented communities promoted the study to their respective diverse populations. Lastly, targeted digital, television, and print media promoted the study broadly.
The site staff were not enrolled in the clinical trial that is represented in the overall study flow diagram above and as such are not included in it. They were engaged in a post hoc interview to understand the study results for an exploratory analysis.
Participant milestones
| Measure |
Self Monitored
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Overall Study
STARTED
|
185
|
186
|
187
|
|
Overall Study
COMPLETED
|
139
|
132
|
102
|
|
Overall Study
NOT COMPLETED
|
46
|
54
|
85
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
Baseline characteristics by cohort
| Measure |
Self Monitored
n=185 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=186 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=187 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Total
n=558 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
42.80 years
STANDARD_DEVIATION 12.9 • n=185 Participants
|
42.8 years
STANDARD_DEVIATION 12.9 • n=186 Participants
|
42.6 years
STANDARD_DEVIATION 12.9 • n=187 Participants
|
42.8 years
STANDARD_DEVIATION 12.9 • n=558 Participants
|
|
Sex: Female, Male
Female
|
120 Participants
n=185 Participants
|
122 Participants
n=186 Participants
|
123 Participants
n=187 Participants
|
365 Participants
n=558 Participants
|
|
Sex: Female, Male
Male
|
65 Participants
n=185 Participants
|
64 Participants
n=186 Participants
|
64 Participants
n=187 Participants
|
193 Participants
n=558 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
4 Participants
n=185 Participants
|
6 Participants
n=186 Participants
|
4 Participants
n=187 Participants
|
14 Participants
n=558 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
181 Participants
n=185 Participants
|
180 Participants
n=186 Participants
|
183 Participants
n=187 Participants
|
544 Participants
n=558 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=185 Participants
|
0 Participants
n=186 Participants
|
0 Participants
n=187 Participants
|
0 Participants
n=558 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
2 Participants
n=185 Participants
|
1 Participants
n=186 Participants
|
0 Participants
n=187 Participants
|
3 Participants
n=558 Participants
|
|
Race (NIH/OMB)
Asian
|
5 Participants
n=185 Participants
|
2 Participants
n=186 Participants
|
4 Participants
n=187 Participants
|
11 Participants
n=558 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=185 Participants
|
1 Participants
n=186 Participants
|
1 Participants
n=187 Participants
|
2 Participants
n=558 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=185 Participants
|
8 Participants
n=186 Participants
|
10 Participants
n=187 Participants
|
25 Participants
n=558 Participants
|
|
Race (NIH/OMB)
White
|
170 Participants
n=185 Participants
|
167 Participants
n=186 Participants
|
170 Participants
n=187 Participants
|
507 Participants
n=558 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=185 Participants
|
3 Participants
n=186 Participants
|
1 Participants
n=187 Participants
|
4 Participants
n=558 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=185 Participants
|
4 Participants
n=186 Participants
|
1 Participants
n=187 Participants
|
6 Participants
n=558 Participants
|
|
Education
< High school
|
0 Participants
n=185 Participants
|
2 Participants
n=186 Participants
|
1 Participants
n=187 Participants
|
3 Participants
n=558 Participants
|
|
Education
HS or GED
|
16 Participants
n=185 Participants
|
19 Participants
n=186 Participants
|
32 Participants
n=187 Participants
|
67 Participants
n=558 Participants
|
|
Education
Vocation or associate
|
35 Participants
n=185 Participants
|
34 Participants
n=186 Participants
|
16 Participants
n=187 Participants
|
85 Participants
n=558 Participants
|
|
Education
Bachelors
|
76 Participants
n=185 Participants
|
83 Participants
n=186 Participants
|
76 Participants
n=187 Participants
|
235 Participants
n=558 Participants
|
|
Education
Masters
|
44 Participants
n=185 Participants
|
29 Participants
n=186 Participants
|
48 Participants
n=187 Participants
|
121 Participants
n=558 Participants
|
|
Education
Doctorate
|
14 Participants
n=185 Participants
|
19 Participants
n=186 Participants
|
14 Participants
n=187 Participants
|
47 Participants
n=558 Participants
|
|
AUDIT Category
Low risk
|
39 Participants
n=185 Participants
|
53 Participants
n=186 Participants
|
41 Participants
n=187 Participants
|
133 Participants
n=558 Participants
|
|
AUDIT Category
Harmful drinking
|
85 Participants
n=185 Participants
|
72 Participants
n=186 Participants
|
84 Participants
n=187 Participants
|
241 Participants
n=558 Participants
|
|
AUDIT Category
Alcohol dependence
|
61 Participants
n=185 Participants
|
61 Participants
n=186 Participants
|
62 Participants
n=187 Participants
|
184 Participants
n=558 Participants
|
|
Percentage of heavy drinking days (PHDD)
|
37.1 percentage
STANDARD_DEVIATION 30.6 • n=185 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
36.2 percentage
STANDARD_DEVIATION 31.2 • n=186 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
41.9 percentage
STANDARD_DEVIATION 31.4 • n=186 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
38.4 percentage
STANDARD_DEVIATION 31.1 • n=557 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
|
Quality of life-physical health, QOL-PH
|
48.4 T-score
STANDARD_DEVIATION 6.3 • n=185 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
48.1 T-score
STANDARD_DEVIATION 6.7 • n=186 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
48.3 T-score
STANDARD_DEVIATION 6.5 • n=186 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
48.3 T-score
STANDARD_DEVIATION 6.5 • n=557 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
|
Quality of life-mental health, QOL-MH
|
45.5 T-scores
STANDARD_DEVIATION 6.9 • n=185 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
45.5 T-scores
STANDARD_DEVIATION 7.5 • n=186 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
45.4 T-scores
STANDARD_DEVIATION 6.9 • n=186 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
45.4 T-scores
STANDARD_DEVIATION 7.1 • n=557 Participants • One participant in the Clinically Integrated group did not submit baseline measures for PHDD, QOL-PH, and QOL-MH, so the sample size for this group and these outcomes was 186, not the original number, 187.
|
PRIMARY outcome
Timeframe: 12 monthsPercentage of self-reported Heavy Drinking Days (HDD: 5 or more standard drinks on any day for men under 65, 4 or more standard drinks for women and men over 65) in the last 7 days
Outcome measures
| Measure |
Self Monitored
n=139 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=130 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=100 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Percentage of Heavy Drinking Days, PHDD
|
24.4 percentage of heavy drinking days
Standard Deviation 28.2
|
21.4 percentage of heavy drinking days
Standard Deviation 28.9
|
21.3 percentage of heavy drinking days
Standard Deviation 30.4
|
PRIMARY outcome
Timeframe: 12 monthsThe physical health subscale of Patient Reported Outcomes Measurement Information System (PROMIS) Global-10 short form was used to assess the quality of life-physical health (QoL-PH). It consists of 4 questions that assess overall physical health aspect of quality of life. Each question will ask patients to indicate their physical health on a scale of 1 (poor) to 5 (excellent). The raw scores of physical health scores (range: 0 to 20) are converted to T-scores (16.2 to 67.7). Higher scores mean better physical health aspects of quality of life.
Outcome measures
| Measure |
Self Monitored
n=139 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=130 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=100 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Quality of Life-Physical Health
|
48.5806 T-Scores
Standard Deviation 6.81051
|
49.2869 T-Scores
Standard Deviation 6.44004
|
48.1010 T-Scores
Standard Deviation 7.45609
|
PRIMARY outcome
Timeframe: 12 monthsThe mental health subscale of Patient Reported Outcomes Measurement Information System (PROMIS) Global-10 short form was used to assess the quality of life-mental health (QoL-MH). It consists of 4 questions that assess overall mental health aspect of quality of life. Each question will ask patients to indicate their mental health on a scale of 1 (poor) to 5 (excellent). The raw scores of mental health scores (range: 0 to 20) are converted to T-scores (21.2 to 67.6). Higher scores mean better mental health aspects of quality of life.
Outcome measures
| Measure |
Self Monitored
n=139 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=130 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=100 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Quality of Life-Mental Health
|
46.7439 T-Scores
Standard Deviation 8.25969
|
47.6715 T-Scores
Standard Deviation 8.30113
|
48.1160 T-Scores
Standard Deviation 7.03693
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: We did not collect data for this metric.
Patients in the clinically-integrated arm will have the option to share their data collected by A-CHESS with the health coach. Knowing how many patients are willing to share data about their drinking will allow researchers to make hypotheses about how effective A-CHESS can be in a healthcare setting. We did not collect data for this metric.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 12 monthsPatients will be asked to indicate hospital stay (nights) in the past 6 months. Researchers will include this in the cost-effectiveness analysis.
Outcome measures
| Measure |
Self Monitored
n=131 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=128 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=101 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Number of Hospital Nights in the Past 6 Months
|
0.0534 Hospital nights
Standard Deviation 0.35762
|
0.0469 Hospital nights
Standard Deviation 0.39404
|
0.2178 Hospital nights
Standard Deviation 1.34613
|
SECONDARY outcome
Timeframe: up to 3 yearsPopulation: Cost reflects total number enrolled, not number completed, to account for program being at full capacity.
The cost (in US dollars) of the intervention will be calculated to determine cost-effectiveness of the study.
Outcome measures
| Measure |
Self Monitored
n=185 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=186 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=187 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Cost of Implementation of Each Intervention Arm in US Dollars
|
0 dollars
|
71750 dollars
|
124250 dollars
|
SECONDARY outcome
Timeframe: 12 monthsThe Alcohol Use Disorders Identification Test (AUDIT) screening tool was used to assess patient alcohol severity. The screening tool consists of 10 questions with 5 possible answers (scoring 0-4). The sum scores of the 10 items are the scale scores ranging from 0 to 40. Higher scores indicate greater alcohol severity.
Outcome measures
| Measure |
Self Monitored
n=132 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=127 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=99 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Score of Alcohol Use Disorders Identification Test (AUDIT) Screening Tool
|
9.0303 Scores on a scale
Standard Deviation 4.91289
|
9.3386 Scores on a scale
Standard Deviation 5.9271
|
8.8283 Scores on a scale
Standard Deviation 5.54948
|
SECONDARY outcome
Timeframe: 12 monthsThe Diagnostic and Statistical Manual of Mental Disorders 5th edition criteria of alcohol use disorder will be used to assess the patient's alcohol use disorder severity. Each item has a score of 1 for agreement or 0 for disagreement of a statement. The sum score of all 11 items is the scale score (range of 0-11 - higher scores indicate greater severity). The severity of the AUD can also be defined as 1) mild: 2 to 3 symptoms; 2) moderate: 4 to 5 symptoms; 3) severe: 6+ symptoms.
Outcome measures
| Measure |
Self Monitored
n=110 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=109 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=71 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Score of the Diagnostic and Statistical Manual- 5 Alcohol Use Disorder (AUD) Severity
|
2.5364 Scores on a scale
Standard Deviation 1.76447
|
2.5229 Scores on a scale
Standard Deviation 1.65326
|
2.9178 Scores on a scale
Standard Deviation 2.17763
|
SECONDARY outcome
Timeframe: 12 monthsThe study will assess how connected patients feel with others. Greater connectedness is associated with fewer risky drinking days. Patients are asked five Likert-scale questions about their relationships with others, responding on a 1-5 scale from 'Never' to 'Nearly Always.' Mean scores are calculated as scale scores, ranging from 1 to 5. Higher scores indicate greater perceived relatedness with others.
Outcome measures
| Measure |
Self Monitored
n=139 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=130 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=100 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Score of Relatedness as Assessed by the CHESS Bonding Scale
|
2.3022 Scores
Standard Deviation 0.85985
|
2.7538 Scores
Standard Deviation 0.87037
|
2.668 Scores
Standard Deviation 0.95525
|
SECONDARY outcome
Timeframe: 12 monthsThe study will assess patients' perceptions of their ability to control and reduce their drinking in order to meet their alcohol use goals. Patients tend to drink less when they feel more confident in managing their alcohol use. Patients will respond to four questions from the Perceived Competence Scale (PCS) about their confidence in responsibly managing alcohol use in various situations. Responses are on a 1-7 scale, from 'Not at all' to 'Very true.' Mean scores (ranging from 1 to 7) are used as the scale scores, with higher scores indicating greater confidence in controlling or reducing drinking.
Outcome measures
| Measure |
Self Monitored
n=138 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=130 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=87 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Score of Competence as Assessed by the Perceived Competence Scale (PCS)
|
5.1377 Scores
Standard Deviation 1.26652
|
5.0788 Scores
Standard Deviation 1.34071
|
5.39 Scores
Standard Deviation 1.50013
|
SECONDARY outcome
Timeframe: 12 monthsThe study assesses how motivated patients are by their own goals. Patients typically drink less when they, themselves, want to reduce their alcohol. Patients will be asked 6 questions from the autonomous motivation subscale of the Treatment Self-Regulation Questionnaire (TSRQ) about why they will reduce their alcohol use and can indicate how much they identify with each statement on a 1-5 scale corresponding to "Not true" to "Very true", respectively. The mean scores are the scale scores, ranging from 1 to 5. Higher scores mean more autonomous motivation to control and reduce alcohol use.
Outcome measures
| Measure |
Self Monitored
n=138 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=130 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=100 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Score of Autonomous Motivation as Assessed by Revised Treatment Self Regulation Questionnaire
|
3.8913 Scores
Standard Deviation 0.67081
|
3.9244 Scores
Standard Deviation 0.7311
|
4.0283 Scores
Standard Deviation 0.811
|
SECONDARY outcome
Timeframe: 12 monthsThe time that participants spent using Tula will be assessed.
Outcome measures
| Measure |
Self Monitored
n=185 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=186 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=187 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Time of Tula Used
|
17142.98 Seconds
Standard Deviation 15043.75
|
19851.64 Seconds
Standard Deviation 16160.12
|
17000.83 Seconds
Standard Deviation 12961.23
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: We did not implement this setback alert so no data are collected for this measure.
The patient's ability to meet their weekly goal will be assessed. When patients are not on track to meet their weekly goal a setback alert will be triggered.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: up to 3 yearsPopulation: We did not implement this setback alert so no data are collected for this measure.
The variables that help predict a setback will be assessed and reported. Knowing the variables for setbacks will help researchers program A-CHESS to better predict when patients are likely to have a setback.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: up to 3 yearsPopulation: We did not implement this setback alert so no data are collected for this measure.
Clinicians and patients will be alerted when the system predicts that they may have a setback. This allows researchers to know how useful patients and health coaches found the alerts.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 12 MonthsThe number of pages viewed by patients and health coaches will be assessed know how useful patients found different content.
Outcome measures
| Measure |
Self Monitored
n=185 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=186 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=187 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Pages Viewed on A-CHESS
|
753.12 Page view counts
Standard Deviation 517.05
|
891.84 Page view counts
Standard Deviation 544.44
|
773.1 Page view counts
Standard Deviation 458.18
|
SECONDARY outcome
Timeframe: 12 monthsPatients will take a revised Brief Alcohol Monitor survey weekly that asks patients to indicate whether any of the five protection factors exist (sleep, mood, social interaction, work, and urges to drink). The protective factor score is the sum of the number of protection factor items reported by patients during the study period. The scores of the protective factors were planned to be used in the lapse prediction model. Since the study plan changes and the lapse prediction was not the focus of the study, only descriptive statistics are reported. No additional statistical analysis was conducted. Scores range from 7-35. Lower scores indicate a worse outcome for each factor.
Outcome measures
| Measure |
Self Monitored
n=113 Participants
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Peer Supported
n=113 Participants
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
Clinically Integrated
n=73 Participants
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
|
|---|---|---|---|
|
Number of Patient Protection Factors Assessed by a Revised Brief Alcohol Monitor
|
21.96 Score on a scale
Standard Deviation 5.45
|
23.02 Score on a scale
Standard Deviation 5.25
|
23.48 Score on a scale
Standard Deviation 5.63
|
Adverse Events
Self Monitored
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Peer Supported
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Clinically Integrated
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Andrew Quanbeck
Dept of Family Medicine and Community Health, UW-Madison
Phone: 608-609-7308
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place